Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

21 Jul 2014 14:32

RNS Number : 8806M
Unicorn AIM VCT PLC
21 July 2014
 



Unicorn AIM VCT plc

 

Interim Management Statement

 

For the period from 1 April 2014 to 30 June 2014

 

Introduction

 

The Company has prepared this Interim Management Statement (IMS) in accordance with the Disclosure and Transparency Rules of the UK Listing Authority. The IMS covers the three month period ended 30 June 2014, together with relevant information up to the date of publication.

 

Investment Objective

 

The objective of the Company is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maximising the stream of dividend distributions to Shareholders from the income and capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust, so that Shareholders benefit from the taxation advantages that this brings. To achieve this at least 70% of the Company's total assets are to be invested in qualifying investments of which 30% by value must be in ordinary shares carrying no preferential rights to dividends or return of capital and no rights to redemption.

 

Performance

 

The three month period to 30 June 2014 was one of continued modest progress for the main UK equity market. Over the period as a whole, the FTSE All-Share Index (excluding investment trusts) registered a total return of +2.3%. By contrast, the FTSE AIM All-Share Index suffered quite badly, recording a total return of -7.5%.

 

The Company again delivered strong relative outperformance during the period, with Net Asset Value (NAV) increasing by +3.7%. NAV performance is calculated on a total return basis, after adding back dividends paid. No dividends were paid in the period.

 

As at 30 June 2014, the unaudited NAV was 148.1 pence per share, compared to an unaudited NAV of 142.8 pence per share as at 31 March 2014. Net assets amounted to £94.6m at the period end, consolidating Unicorn's position as the largest AIM focused VCT in the market.

A number of VCT qualifying holdings performed particularly strongly in the period under review. The most notable of these were:-

Accumuli (+26.5%), is an independent specialist in IT Security and Risk Management, that continues to develop through a combination of organic growth and selective acquisition. In its financial year ended 31 March 2014, Accumuli recorded an 18% growth in revenues and a 32% increase in adjusted profits before tax. This strong performance has resulted in a 15% increase in the proposed dividend. Accumuli's customer base has more than doubled in the past year and now stands at over 700, which underpins the prospects for continued growth.

 

Crawshaw Group (+116.1%), a Yorkshire based chain of retail butchers. In the three months to 30 June 2014, Crawshaw's share price rose by 116% driven by a series of positive trading updates. Following the period end, Crawshaw announced an £8.8m conditional placing of new shares in order to help finance a significant acceleration of their store opening programme. Unicorn AIM VCT committed a further £1m to support this fundraising. It is anticipated that this new investment will be VCT qualifying.

Tristel (+74.2%), a manufacturer of infection prevention, contamination control and hygiene products. Tristel shares performed particularly strongly in the period under review following the release of two successive trading updates in which profit forecasts were meaningfully upgraded.

Other notable contributions came from Cohort (+27.9%), HML Holdings (+19.8%), IDOX (+14.1%) and Tracsis (+21.7%).

During the period, there were only a small number of holdings that performed poorly. In addition, most of the investee companies that did experience share price declines, were affected by technical factors (such as profit-taking), rather than by problems surrounding operational issues or materially disappointing trading.

 

In terms of negative absolute contribution, the three worst performers were; Hasgrove (-32.9%), Mears Group (-10.8%), and Omega Diagnostics (-22.6%).

 

Material Transactions

 

Three investments were made in the period:-

Arbuthnot Banking Group, an AIM listed banking group with interests in private and retail banking. This investment is non-qualifying for VCT purposes.

Heartstone Inns, a privately owned pub chain which has raised capital under VCT qualifying rules to help accelerate the expansion of its estate of freehold pubs.

WYG, a specialist project management and technical consultancy business. A further purchase of non VCT qualifying shares in WYG was made in the period.

In total, almost £2.8m was committed to these new investment opportunities.

There was one disposal made in the period:-

Pilat Media Global, a business focused on providing software solutions to the global media sector, was acquired for cash by Sintec Media, a trade competitor. It is anticipated that the final cash proceeds from this disposal will amount to just over £475,000.

Top 10 Equity Holdings at 30 June 2014

Stock

% of fund

Abcam

7.1%

Tracsis

6.9%

Anpario

5.7%

Mattioli Woods

4.7%

Unicorn UK Smaller Companies Fund

4.2%

Pressure Technologies

3.6%

Crawshaw Group

3.5%

Mears Group

3.4%

Cohort

2.8%

Avingtrans

2.7%

Total

44.6%

 

Share Buy-Backs / Issue of Equity

 

During the period from 1 April 2014 to 30 June 2014, the Company bought back 583,340 of its own Ordinary Shares for cancellation, at an average price of £1.25 per share.

 

In the same period, 4,025,467 Ordinary shares were issued under the Offer for Subscription, at an average price of £1.48 per share.

 

After the period end, a final allotment of 675,629 Ordinary Shares was made in relation to this Offer for Subscription, which has now closed.

 

In total, £13.74m of additional capital has been raised under this Offer for Subscription, which closed on 30 June 2014. The Board would like to take this opportunity to welcome new shareholders and to thank all shareholders for their continued support.

 

There were 64,550,193 Ordinary Shares in issue at the date of this announcement.

 

Material Events

 

Since the period end, a £1.25m non-qualifying investment was made in Epwin Group, a manufacturer and supplier of building products predominantly to the UK residential housing market. Epwin is being admitted to AIM and its shares are scheduled to commence trading on 24 July 2014.

 

There were no other material events during the period from 1 April 2014 to 30 June 2014.

 

Contact details for further enquiries:

 

Chris Hutchinson of Unicorn Asset Management Limited (the Investment Manager),

on 020 7253 0889.

 

Robert Brittain at Mobeus Equity Partners LLP (the Company Secretary)

on 020 7024 7600 or by e-mail on unicorn@mobeusequity.co.uk

 

DISCLAIMER

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGZNFMGGDZM
Date   Source Headline
14th Dec 20227:00 amRNSFinal Results
8th Dec 202210:12 amRNSIntention to Launch an Offer
5th Dec 20222:43 pmRNSNet Asset Value(s)
4th Nov 20225:47 pmRNSNet Asset Value(s)
21st Oct 20221:38 pmRNSNet Asset Value(s)
3rd Oct 202212:45 pmRNSTotal Voting Rights
20th Sep 20226:19 pmRNSTransaction in Own Shares
5th Sep 202212:32 pmRNSNet Asset Value(s)
11th Aug 202211:27 amRNSIssue of Equity
4th Aug 20222:47 pmRNSNet Asset Value(s)
26th Jul 202211:30 amRNSInterim Management Statement
7th Jul 20229:50 amRNSNet Asset Value(s)
1st Jul 202210:00 amRNSTotal Voting Rights
22nd Jun 20225:44 pmRNSTransaction in Own Shares
14th Jun 20223:27 pmRNSNet Asset Value(s)
10th Jun 20227:00 amRNSHalf-year Report
24th May 20222:26 pmRNSDirectorate Change
6th May 202212:33 pmRNSNet Asset Value(s)
11th Apr 20229:02 amRNSNet Asset Value(s) Replacement
7th Apr 20223:14 pmRNSNet Asset Value(s)
1st Apr 202210:43 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20221:40 pmRNSDirector/PDMR Shareholding
4th Mar 202212:44 pmRNSTotal Voting Rights
4th Mar 202212:39 pmRNSIssue of Equity
2nd Mar 20222:26 pmRNSNet Asset Value(s)
1st Mar 20229:58 amRNSTotal Voting Rights
18th Feb 20221:27 pmRNSInterim Management Statement
15th Feb 20224:51 pmRNSTransaction in Own Shares
10th Feb 20227:00 amRNSIssue of Equity
9th Feb 202212:11 pmRNSOffer for Subscription - Update
7th Feb 202210:12 amRNSNet Asset Value(s)
3rd Feb 20221:34 pmRNSResult of AGM
1st Feb 202211:52 amRNSTotal Voting Rights
24th Jan 202210:17 amRNSOffer for Subscription and Issue of Prospectus
17th Jan 202212:44 pmRNSTransaction in Own Shares
6th Jan 20222:49 pmRNSNet Asset Value(s)
4th Jan 20229:41 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSTransaction in Own Shares
16th Dec 202112:33 pmRNSConfirmation of Dividends
14th Dec 20211:48 pmRNSNet Asset Value(s)
8th Dec 20217:00 amRNSFinal Results
22nd Nov 20215:07 pmRNSDeclaration of Special Dividend
4th Nov 20215:47 pmRNSNet Asset Value(s)
26th Oct 20213:07 pmRNSIntention to launch an Offer
18th Oct 20214:34 pmRNSNet Asset Value(s)
1st Oct 202111:46 amRNSTotal Voting Rights
10th Sep 20213:52 pmRNSTransaction in Own Shares
1st Sep 20212:46 pmRNSTotal Voting Rights
16th Aug 202110:57 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.